118 related articles for article (PubMed ID: 28986304)
1. Molecular profiles of oxyphilic and chief cell parathyroid adenoma.
Lu M; Kjellin H; Fotouhi O; Lee L; Nilsson IL; Haglund F; Höög A; Lehtiö J; Larsson C
Mol Cell Endocrinol; 2018 Jul; 470():84-95. PubMed ID: 28986304
[TBL] [Abstract][Full Text] [Related]
2. Molecular pathogenesis of primary hyperparathyroidism.
Arnold A; Shattuck TM; Mallya SM; Krebs LJ; Costa J; Gallagher J; Wild Y; Saucier K
J Bone Miner Res; 2002 Nov; 17 Suppl 2():N30-6. PubMed ID: 12412775
[TBL] [Abstract][Full Text] [Related]
3. A Possible Link Between Parathyroid Hormone Secretion and Local Regulation of GABA in Human Parathyroid Adenomas.
Hong AR; Kim YA; Bae JH; Min HS; Kim JH; Shin CS; Kim SY; Kim SW
J Clin Endocrinol Metab; 2016 Jun; 101(6):2594-601. PubMed ID: 27070188
[TBL] [Abstract][Full Text] [Related]
4. Reduced vitamin D receptor expression in parathyroid adenomas: implications for pathogenesis.
Sudhaker Rao D; Han ZH; Phillips ER; Palnitkar S; Parfitt AM
Clin Endocrinol (Oxf); 2000 Sep; 53(3):373-81. PubMed ID: 10971456
[TBL] [Abstract][Full Text] [Related]
5. Increased protein kinase A type Iα regulatory subunit expression in parathyroid gland adenomas of patients with primary hyperparathyroidism.
Hibi Y; Kambe F; Imai T; Ogawa K; Shimizu Y; Shibata M; Kagawa C; Mizuno Y; Ito A; Iwase K
Endocr J; 2013; 60(2):215-23. PubMed ID: 23197043
[TBL] [Abstract][Full Text] [Related]
6. Methylation status of the CpG islands in vitamin D and calcium-sensing receptor gene promoters does not explain the reduced gene expressions in parathyroid adenomas.
Varshney S; Bhadada SK; Sachdeva N; Arya AK; Saikia UN; Behera A; Rao SD
J Clin Endocrinol Metab; 2013 Oct; 98(10):E1631-5. PubMed ID: 23913941
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous expression analysis of vitamin D receptor, calcium-sensing receptor, cyclin D1, and PTH in symptomatic primary hyperparathyroidism in Asian Indians.
Varshney S; Bhadada SK; Saikia UN; Sachdeva N; Behera A; Arya AK; Sharma S; Bhansali A; Mithal A; Rao SD
Eur J Endocrinol; 2013 Jul; 169(1):109-16. PubMed ID: 23660642
[TBL] [Abstract][Full Text] [Related]
8. Oxyphilic cell adenoma of parathyroid resulting in primary hyperparathyroidism and osteitis fibrosa cystica--a case report.
Prasad KK; Agarwal G; Mishra SK; Krishnani N
Indian J Pathol Microbiol; 2006 Jul; 49(3):448-50. PubMed ID: 17001919
[TBL] [Abstract][Full Text] [Related]
9. Reduced Calcium Sensing Receptor (CaSR) Expression Is Epigenetically Deregulated in Parathyroid Adenomas.
Singh P; Bhadada SK; Dahiya D; Arya AK; Saikia UN; Sachdeva N; Kaur J; Brandi ML; Rao SD
J Clin Endocrinol Metab; 2020 Sep; 105(9):3015-24. PubMed ID: 32609827
[TBL] [Abstract][Full Text] [Related]
10. Aryl hydrocarbon receptor interacting protein (AIP) mutations occur rarely in sporadic parathyroid adenomas.
Pardi E; Marcocci C; Borsari S; Saponaro F; Torregrossa L; Tancredi M; Raspini B; Basolo F; Cetani F
J Clin Endocrinol Metab; 2013 Jul; 98(7):2800-10. PubMed ID: 23633209
[TBL] [Abstract][Full Text] [Related]
11. Gene expression profiles in parathyroid adenoma and normal parathyroid tissue.
Kim SW
Vitam Horm; 2022; 120():289-304. PubMed ID: 35953114
[TBL] [Abstract][Full Text] [Related]
12. Decrease in vitamin D receptor and calcium-sensing receptor in highly proliferative parathyroid adenomas.
Yano S; Sugimoto T; Tsukamoto T; Chihara K; Kobayashi A; Kitazawa S; Maeda S; Kitazawa R
Eur J Endocrinol; 2003 Apr; 148(4):403-11. PubMed ID: 12656660
[TBL] [Abstract][Full Text] [Related]
13. Preoperative localization of parathyroid adenomas with technetium-99m methoxyisobutylisonitrile imaging: relationship with P-glycoprotein expression, oxyphilic cell content, and tumoral tissue volume.
Turgut B; Elagoz S; Erselcan T; Koyuncu A; Dokmetas HS; Hasbek Z; Ozdemir S; Aydin C
Cancer Biother Radiopharm; 2006 Dec; 21(6):579-90. PubMed ID: 17257073
[TBL] [Abstract][Full Text] [Related]
14. Morphological evaluation of parathyroid adenomas and immunohistochemical analysis of PCNA and Ki-67 proliferation markers.
Demıralay E; Altaca G; Demırhan B
Turk Patoloji Derg; 2011; 27(3):215-20. PubMed ID: 21935871
[TBL] [Abstract][Full Text] [Related]
15. Underexpression of Gcm2, a master regulatory gene of parathyroid gland development, in adenomas of primary hyperparathyroidism.
Correa P; Akerström G; Westin G
Clin Endocrinol (Oxf); 2002 Oct; 57(4):501-5. PubMed ID: 12354132
[TBL] [Abstract][Full Text] [Related]
16. Parathyroid function and histology in patients with parathyroid adenoma: correlation of clinical and morphologic findings.
Luts L; Bergenfelz A; Alumets J; Sundler F
World J Surg; 1997 Jun; 21(5):553-63. PubMed ID: 9204747
[TBL] [Abstract][Full Text] [Related]
17. Analysis of Activating GCM2 Sequence Variants in Sporadic Parathyroid Adenomas.
Riccardi A; Aspir T; Shen L; Kuo CL; Brown TC; Korah R; Murtha TD; Bellizzi J; Parham K; Carling T; Costa-Guda J; Arnold A
J Clin Endocrinol Metab; 2019 Jun; 104(6):1948-1952. PubMed ID: 30624640
[TBL] [Abstract][Full Text] [Related]
18. Loss of p27 expression is associated with MEN1 gene mutations in sporadic parathyroid adenomas.
Borsari S; Pardi E; Pellegata NS; Lee M; Saponaro F; Torregrossa L; Basolo F; Paltrinieri E; Zatelli MC; Materazzi G; Miccoli P; Marcocci C; Cetani F
Endocrine; 2017 Feb; 55(2):386-397. PubMed ID: 27038812
[TBL] [Abstract][Full Text] [Related]
19. Reduced parathyroid vitamin D receptor messenger ribonucleic acid levels in primary and secondary hyperparathyroidism.
Carling T; Rastad J; Szabó E; Westin G; Akerström G
J Clin Endocrinol Metab; 2000 May; 85(5):2000-3. PubMed ID: 10843188
[TBL] [Abstract][Full Text] [Related]
20. Oncocytic parathyroid adenoma: problem in cytological diagnosis.
Giorgadze T; Stratton B; Baloch ZW; Livolsi VA
Diagn Cytopathol; 2004 Oct; 31(4):276-80. PubMed ID: 15452901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
